Activation of the Prostanoid FP Receptor Inhibits Adipogenesis Leading to Deepening of the Upper Eyelid Sulcus in Prostaglandin-Associated Periorbitopathy-Reference-Cited by-同舟云学术

Activation of the Prostanoid FP Receptor Inhibits Adipogenesis Leading to Deepening of the Upper Eyelid Sulcus in Prostaglandin-Associated Periorbitopathy

Published:2014-03-04 Issue:3 Volume:55 Page:1269
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Taketani Yukako¹,Yamagishi Reiko²,Fujishiro Takashi³,Igarashi Masaki⁴,Sakata Rei⁵,Aihara Makoto²

Affiliation:

1. Department of Ophthalmology, University of Tokyo, Tokyo, Japan 2Asahi Chuo Hospital, Chiba, Japan

2. Department of Ophthalmology, University of Tokyo, Tokyo, Japan

3. Department of Ophthalmology, University of Tokyo, Tokyo, Japan 3Saitama Sekijuji Hospital, Saitama, Japan

4. Department of Diabetes and Metabolism, University of Tokyo, Tokyo, Japan

5. Department of Ophthalmology, University of Tokyo, Tokyo, Japan 5Tokyo Metropolitan Geriatric Hospital, Itabashi, Tokyo, Japan

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Staging of Prostaglandin-Associated Periorbitopathy Syndrome in Glaucoma: A Review from Asia;Seminars in Ophthalmology;2024-06-06

2. From Eye Care to Hair Growth: Bimatoprost;Pharmaceuticals;2024-04-27

3. Recovery from Upper Eyelid Sulcus Deepening Following Switch from Prostaglandin Analogues to EP2 Receptor Agonist;Journal of the Korean Ophthalmological Society;2023-10-15

4. Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy;Frontiers in Toxicology;2023-07-21

5. Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment;The Ocular Surface;2023-07